NO20003273D0 - Substituerte <beta>-alaniner - Google Patents
Substituerte <beta>-alaninerInfo
- Publication number
- NO20003273D0 NO20003273D0 NO20003273A NO20003273A NO20003273D0 NO 20003273 D0 NO20003273 D0 NO 20003273D0 NO 20003273 A NO20003273 A NO 20003273A NO 20003273 A NO20003273 A NO 20003273A NO 20003273 D0 NO20003273 D0 NO 20003273D0
- Authority
- NO
- Norway
- Prior art keywords
- beta
- compounds
- prodrugs
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
| US9260298P | 1998-07-13 | 1998-07-13 | |
| PCT/GB1998/003859 WO1999033789A1 (fr) | 1997-12-23 | 1998-12-23 | β-ALANINES SUBSTITUEES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003273L NO20003273L (no) | 2000-06-22 |
| NO20003273D0 true NO20003273D0 (no) | 2000-06-22 |
Family
ID=26312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003273A NO20003273D0 (no) | 1997-12-23 | 2000-06-22 | Substituerte <beta>-alaniner |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1042279B1 (fr) |
| JP (1) | JP4555469B2 (fr) |
| KR (1) | KR20010033520A (fr) |
| CN (1) | CN1163477C (fr) |
| AT (1) | ATE289991T1 (fr) |
| AU (1) | AU747907B2 (fr) |
| BR (1) | BR9814376A (fr) |
| CA (1) | CA2316235A1 (fr) |
| CZ (1) | CZ20002342A3 (fr) |
| DE (1) | DE69829215T2 (fr) |
| ES (1) | ES2235383T3 (fr) |
| HK (1) | HK1034508A1 (fr) |
| HU (1) | HUP0101701A3 (fr) |
| IL (1) | IL136584A (fr) |
| NO (1) | NO20003273D0 (fr) |
| NZ (1) | NZ505363A (fr) |
| SK (1) | SK9372000A3 (fr) |
| TR (1) | TR200001947T2 (fr) |
| WO (1) | WO1999033789A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200000428A (et) * | 1998-01-23 | 2001-12-17 | Novartis Ag | VLA-4 antagonistid |
| AU1881900A (en) * | 1998-12-23 | 2000-07-31 | Aventis Pharma Limited | Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
| PT1154993E (pt) * | 1999-02-18 | 2005-01-31 | Hoffmann La Roche | Derivados de tioamida |
| JP2003519697A (ja) | 1999-12-28 | 2003-06-24 | ファイザー・プロダクツ・インク | 炎症性疾患、自己免疫疾患および呼吸器疾患の処置に有用な非ペプチド系のｖｌａ−４依存性細胞結合阻害薬 |
| DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
| FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
| GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| CA2427750C (fr) * | 2000-11-04 | 2011-01-04 | Aventis Pharma Limited | Acides alcanoiqies substitues |
| US7157487B2 (en) | 2000-12-28 | 2007-01-02 | Daiichi Pharmaceutical Co., Ltd. | Vla-4 inhibitors |
| GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
| JP4676884B2 (ja) | 2003-07-24 | 2011-04-27 | 第一三共株式会社 | シクロヘキサンカルボン酸類 |
| WO2006116399A2 (fr) * | 2005-04-28 | 2006-11-02 | Ferring B.V. | Utilisation de nouveaux composes dans le traitement des maladies inflammatoires intestinales |
| WO2007069635A1 (fr) | 2005-12-13 | 2007-06-21 | Daiichi Sankyo Company, Limited | Médicament inhibiteur de vla-4 |
| EP2124996A4 (fr) | 2007-02-20 | 2010-03-24 | Merrimack Pharmaceuticals Inc | Méthodes de traitement de la sclérose en plaques par administration d'une alpha-foetoprotéine combinée à un antagoniste de l'intégrine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| ES2161373T3 (es) * | 1995-08-30 | 2001-12-01 | Searle & Co | Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas. |
| ATE204857T1 (de) * | 1996-03-29 | 2001-09-15 | Searle & Co | Meta-substituierte phenylenderivate und ihre verwendung als alphavbeta3 intergrin-antagonisten oder inhibitoren |
| ATE212978T1 (de) * | 1996-03-29 | 2002-02-15 | Searle & Co | Para-substituierte phenylpropansäure derivate als integrin-antagonisten |
| EP1027328B1 (fr) * | 1997-10-31 | 2006-08-23 | Aventis Pharma Limited | Anilides substituees |
-
1998
- 1998-12-23 EP EP98962586A patent/EP1042279B1/fr not_active Expired - Lifetime
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Application Discontinuation
- 1998-12-23 CA CA002316235A patent/CA2316235A1/fr not_active Abandoned
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/fr active Search and Examination
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273D0/no not_active Application Discontinuation
-
2001
- 2001-07-27 HK HK01105254A patent/HK1034508A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU747907B2 (en) | 2002-05-30 |
| CZ20002342A3 (cs) | 2001-11-14 |
| ATE289991T1 (de) | 2005-03-15 |
| WO1999033789A1 (fr) | 1999-07-08 |
| NZ505363A (en) | 2005-02-25 |
| NO20003273L (no) | 2000-06-22 |
| JP4555469B2 (ja) | 2010-09-29 |
| JP2001527061A (ja) | 2001-12-25 |
| AU1771999A (en) | 1999-07-19 |
| KR20010033520A (ko) | 2001-04-25 |
| EP1042279B1 (fr) | 2005-03-02 |
| HUP0101701A3 (en) | 2003-02-28 |
| CA2316235A1 (fr) | 1999-07-08 |
| ES2235383T3 (es) | 2005-07-01 |
| CN1163477C (zh) | 2004-08-25 |
| TR200001947T2 (tr) | 2001-01-22 |
| HUP0101701A2 (hu) | 2001-11-28 |
| DE69829215D1 (de) | 2005-04-07 |
| DE69829215T2 (de) | 2005-07-21 |
| EP1042279A1 (fr) | 2000-10-11 |
| BR9814376A (pt) | 2000-10-10 |
| IL136584A0 (en) | 2001-06-14 |
| HK1034508A1 (en) | 2001-10-26 |
| IL136584A (en) | 2005-03-20 |
| SK9372000A3 (en) | 2002-03-05 |
| CN1283181A (zh) | 2001-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE289991T1 (de) | Substituierte beta-alaninen | |
| DK1027328T3 (da) | Substituerede anilider | |
| DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
| TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
| HUP0204496A2 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
| IT1295694B1 (it) | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica | |
| SE9604786D0 (sv) | New compounds | |
| DK0759919T3 (da) | Azolidindioner som antihyperglykæmiske midler | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| CO4820432A1 (es) | Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina | |
| DE69204041D1 (de) | Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung. | |
| HUP0102025A2 (hu) | Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69512208T2 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
| PT1068184E (pt) | Derivados n-ariloxietilamina para o tratamento de depressao | |
| EP0638564A4 (fr) | Derive de benzothiazolesulfonamide, procede de production et application de ce derive. | |
| PT89082A (pt) | Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico | |
| ATE245986T1 (de) | Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen | |
| NO950177L (no) | Farmakologisk aktive erivater | |
| ATE203533T1 (de) | INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN | |
| TR200402493T4 (tr) | Yeni 2,3-benzodiazepin türevleri ve aktif bileşen olarak bunları içeren farmasötik bileşimler. | |
| ES535305A0 (es) | Un procedimiento para preparar n-(2,6-aromatico disustituido)-n'-piridinil-ureas | |
| BR9507668A (pt) | Intermédio para preparar um composto farmaceuticamente atívo | |
| DE69400908D1 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |